Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian RatsJuho‐Matti Renko(University of Helsinki), Yulia Sidorova(University of Helsinki)Journal of Parkinson s DiseaseMay 18, 202110.3233/jpd-202400Cited by 25SaveCiteExport RISWatch citationsRelated PapersA Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat|Frontiers in Pharmacology|2017|58